ABSTRACT
INTRODUCTION
Apoptosis, or programmed cell death, is an important regulator of growth, development, defense, and homeostasis in multicellular organisms (17, 33) . A family of cysteine proteases known as caspases is central to many apoptotic pathways (29) . Caspases cleave at the carboxyl end of a four amino acid consensus site that ends in aspartic acid (28, 31) . In non-apoptotic cells, the inactive precursor forms of these enzymes, known as procaspases, are constitutively expressed. Procaspases are activated by the proteolytic removal of the prodomain and the formation of heterodimers (13, 18, 20) .
There are two classes of caspases involved in apoptosis. The initiator caspases-2, -8, -9, and -10 propagate and perhaps amplify the apoptotic signal (20) . The executioner caspases-3, -6, and -7 are responsible for cleaving cytoskeleton regulatory proteins (i.e., gelsolin and focal adhesion kinase), nuclear structures (lamins), DNA repair proteins (DNA-PK cs ), and the inhibitors of DNases (I cad /DFF45) (20, 25, 31) . The destruction or deregulation of these and other cellular targets culminates in the morphological and chemical characteristics of apoptosis. Since caspases are important mediators of the process, measurements of their activity offer a great tool to detect programmed cell death (26, 37) .
The most common way to assess caspase activity during apoptosis is to use fluorometric or colorimetric substrates. Such substrates are made by conjugating a quencher compound via a specific caspase cleavage site to a fluorophore or chromophore. Caspase cleavage frees the fluorophore or chromophore from the quencher molecule, allowing for detection by fluorescence or light emission (23, 37) . Another popular method uses a biotinylated irreversible caspase inhibitor that binds to active caspase and is detected by immunoblot with streptavidin conjugates (14) .
Recent reports suggest that procaspases have inherent caspase cleavage activity (12, 14, 24) . However, currently available methods only allow the evaluation of in vivo caspase activity at a given time point or over a few hours and may not accurately reflect this endogenous activity. To accurately assess caspase activity in non-apoptotic cells over hours or days, we created a novel, realtime, in vivo marker. The design of this marker utilizes the N-end rule degradation pathway to allow the detection of caspase activity as reflected by increasing the stability of a recombinant enhanced GFP (EGFP). The rate of protein degradation via proteasomes is determined by their N-terminal amino acid (1) . Proteins that have an N-terminal methionine are long-lived in comparison with proteins with an N-terminal arginine (32) . Previously, the N-end rule has been used to examine proteasomal activity (8, 9, 32) ; however, we have applied the N-end rule to study caspase activity. The marker we designed will have an N-terminal arginine in the absence of caspase activity or an N-terminal methionine in the presence of caspase activity within the cell. We have used this marker to analyze caspase activity in non-apoptotic and apoptotic cells.
MATERIALS AND METHODS

Materials
All primers and tissue culture reagents were obtained from Invitrogen (Carlsbad, CA, USA), enzymes were obtained from PanVera (Madison, WI, USA), and all other reagents were obtained from Sigma (St. Louis, MO, USA) unless otherwise noted.
Plasmid Construction
Using a ubiquitin sequence-containing plasmid (a kind gift from Dr. Stewart Lecker, Beth Israel Deaconess Medical Center, Boston, MA) as a template, PCR was performed with the primers 5′-AACCCAAGCTTATGCAGATCT-TCGTCAAG-3′ and 5′-TACCGGATC-CTCGACCACCTCTTAGTCTTAAG-3′. The second PCR used pEGFP-C1 plasmid (BD Biosciences Clontech, Palo Alto, CA, USA) as a template with the primers 5′-TTAGGATCCTTAG-AAACAGACATGGTGAGCAAGGG-CG-3′ and 5′-TGGGAATTCTCACTT-GTACAGCTCGTCC-3′. The control constructs were created by substituting the methionine codon, arginine codon, or both for the underlined codon in the above primers.
The ubiquitin PCR product and the pIND plasmid (Invitrogen) were digested with the restriction enzymes EcoRI/BamHI and ligated by standard molecular biology methods (22) . The resultant plasmid and the pEGFP PCR product were digested with the restriction enzymes BamHI/NotI and ligated. The marker plasmids were verified by DNA sequencing.
Cell Culture
HEK 293T cells were cultured in DMEM with 10% FBS, 100 µg/mL penicillin, and 100 mg/mL streptomycin at 37°C with 5% (v/v) CO 2 .
Tranfection and Induction
Cells previously plated in 60-mm dishes (1 × 10 6 cells/plate) were transfected with 4 µg marker plasmid, 4 µg VgRXR plasmid (Invitrogen), and 1 µg cytomegalovirus (CMV)-β-galactosidase plasmid by the calcium phosphate method (22) . The VgRXR plasmid directs expression of the ecdysone receptor, making cells responsive to Ponasterone A (Invitrogen). Exogenous caspase activity was introduced by co-transfection with the pIND-CD8-Caspase-8 (from 50 ng to 1 µg/transfection) (A kind gift from Richard Siegel, National Institutes of Health, Bethesda, MD), and all cells were transfected with an equal amount of DNA. Twenty-four hours after transfection, the cells were induced with 5 µM Ponasterone A for 24 h.
Immunoblotting
Cells (2 × 10 6 ) were lysed in 50 µL Reporter Lysis Buffer (Promega, Madison, WI, USA), resolved along with broad range molecular weight markers (Bio-Rad Laboratories, Hercules, CA, USA) by SDS-PAGE, and transferred to nitrocellulose membrane as previously described (24) . The membrane was blocked in 5% milk, probed with 1:1000 rabbit anti-GFP (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), and washed in TBS (pH 7.4)/0.1% Tween ® 20 before probing with 1:25 000 HRP-conjugated goat anti-rabbit (Zymed, San Francisco, CA, USA). West-Dura Enhanced Chemiluminescence (Pierce Chemical, Rockford, IL, USA) was added for detection by Fluorchem Imaging System (Alpha InnoTech, San Leandro, CA, USA).
FACS ® Analysis
Cells (5 × 10 5 ) from the collected samples were suspended in 0.5 mL PBS with or without 5 µg/mL propidium iodide (Molecular Probes, Eugene, OR, USA). The cells were sorted by FACScan, and the data were analyzed with CellQuest software (both from BD Biosciences, San Jose, CA, USA).
Fluorescence Quantitation
After 24 h of Ponasterone A induction, the cells were collected and assayed with β-Galactosidase Enzyme Assay System (Promega) using a PowerWave 200 (Bio-Tek Instruments, Winooski, VT, USA). Simultaneous fluorescence was measured in a FL 600 Fluorescent Microplate Reader (BioTek Instruments).
RESULTS
Caspase Marker Design
We designed a marker with the ability to continuously monitor the activity of caspases within intact cells ( Figure  1A ). The marker, R-LETD-M-EGFP, relies on the enzymatic activity of two families of proteases (ubiquitin hydrolases and caspases) and the N-end rule of degradation. Ubiquitin hydrolase, which cleaves co-translationally after ubiquitin with no regard to the subsequent amino acid, is used to produce a protein with an N-terminal arginine, which is targeted for rapid proteasomal degradation by the N-end rule ( Figure  1B ). Caspase cleavage after the consensus sequence lysine-glutamate-threonine-aspartic acid (LETD) eliminates the N-terminal arginine and produces a protein with an N-terminal methionine ( Figure 1B) . Proteins with N-terminal methionine are more stable than their arginine counterparts, which are degraded via the proteasomal pathway at a rate at least 100-fold slower.
To evaluate the in vivo behavior of the marker, R-LETD-M-EGFP, and to determine whether marker synthesis overwhelms the cleavage and degradation pathways, three control markers were constructed ( Figure 1C ). The R-LETD-R-EGFP construct produces a protein with an N-terminal arginine after ubiquitin cleavage and after cleavage of the LETD by caspases. Cells transfected with this plasmid should have minimal fluorescence unless protein production overwhelms degradation pathways, and the fluorescence pattern should not be affected by the presence of caspase activity ( Figure  1C ). Conversely, M-LETD-M-EGFP serves as a positive control since the construct will yield a protein with an Nterminal methionine after ubiquitin cleavage and after cleavage of the LETD by caspases. Cells transfected with this plasmid should have maximum fluorescence unaffected by the presence of caspase activity ( Figure  1C ). Cells transfected with the M-LETD-R-EGFP construct should exhibit maximal and minimal fluorescence under opposite conditions compared with cells transfected with the R-LETD-M-EGFP marker: stable fluorescence after ubiquitin cleavage but rapid degradation after caspase cleavage leaves an N-terminal arginine ( Figure 1C ).
Marker Behavior in Apoptotic Cells
We assessed the changes in total fluorescence of cells expressing M-LETD-R-EGFP and R-LETD-M-EGFP upon co-transfection with the CD8-caspase-8, a plasmid encoding a membrane-bound form of active caspase-8 (11) . The amount of the caspase-8 plasmid transfected into cells was titrated to prevent overwhelming apoptosis. When low amounts of the caspase-8 plasmid are co-transfected into cells with M-LETD-R-EGFP or R-LETD-M-EGFP, cellular fluorescence decreased by more than 50% or increased by 62%, respectively ( Figure  2 ). These reciprocal changes suggest that expression of caspase-8 results in increased cleavage at the LETD site that yields M-EGFP and R-EGFP proteins. The R-EGFP protein has a shorter half-life than M-EGFP, resulting in decreased fluorescence. Although the fluorescence of the cells decreased with the addition of caspase-8, the cells expressing the R-LETD-M-LETD marker consistently demonstrated higher fluorescence than the cells expressing the M-LETD-R-LETD marker (Figure 2 ).
Transfection and EGFP Expression in Eukaryotic Cells
To confirm that the cells transfected with the markers expressed the expected EGFP recombinant protein, immunoblot analysis was performed. No EGFP protein greater than 29.7 kDa was detected in any transfected cells, which is consistent with nearly complete cleavage of the ubiquitin sequence ( Figure 3) . Surprisingly, the cells expressing M-LETD-M-EGFP contained two bands that have EGFP reactivity; one band migrated with an apparent molecular weight of 29.7 kDa, the expected size of EGFP with an intact M-LETD sequence, and another band migrated with an apparent molecular weight of 29.1 kDa, the expected size of M-EGFP. This suggested that caspase activity was present in the cells transfected with the plasmids ( Figure   3 ). The 1:4 ratio of caspase cleaved (29.1 kDa) to uncleaved (29.7 kDa) EGFP indicated that the observed caspase activity was significant. While both cleaved and uncleaved products were expected for other constructs, those with N-terminal arginine should degrade rapidly.
To confirm that all of the expressed proteins could be cleaved by caspases and to evaluate the molecular weight of all construct proteins in the absence and presence of exogenous caspase, we cotransfected the cells with a plasmid encoding for active caspase-8 in a membrane-bound form (11) . Indeed, only the 29.1-kDa recombinant proteins, either M-EGFP or R-EGFP, were detected after the introduction of active caspase-8 ( Figure 3 ). 
Fluorescence Analysis of Eukaryotic Cells Expressing Recombinant EGFP
To normalize expression of EGFP for transfection efficiency, we co-transfected the marker constructs with a plasmid encoding the β-galactosidase gene under the CMV promoter ( Figure  4 of apoptosis by transfection since gating only propidium iodide-negative cells yielded a similar distribution (data not shown).
DISCUSSION
Caspases are involved in many apoptotic pathways. All of the currently available caspase assays examine the activity of the enzyme at a specific point in time and do not allow a kinetic evaluation over hours to days. We developed a marker capable of evaluating caspase activity for an extended period of time. The design of this marker exploits the properties of both ubiquitin hydrolases and the N-end rule of protein degradation, with caspase activity reflected by increasing the stability of EGFP.
Recently, GFP was reported to be an effective N-end rule substrate as R-GFP degraded significantly faster than M-GFP (2,3). In our study, proteolytic removal of ubiquitin from the construct proteins by ubiquitin proteases was evident by the size of the detected EGFP. The pattern of fluorescence was consistent with the N-end rule: cells transfected with R-LETD-R-GFP fluoresced significantly less than those expressing M-LETD-M-GFP. In our expression system, a methionine residue only stabilized the protein 5-fold as compared with an arginine residue (Figure 4) , which is consistent with the findings previously reported for GFP (2) .
In non-apoptotic cells, we assumed that there would be little or no caspase activity. However, by immunoblot, we detected two bands in the cells expressing M-LETD-M-EGFP (Figure 3) . The lower band migrated with the same molecular weight as the single EGFP band detected when caspase-8 was coexpressed in cells. This suggests that caspase activity is present in non-apoptotic cells or that a portion of the transfected cells is apoptotic. Because the population of the cells analyzed by FACS was a normal distribution and the pattern did not change after gating propidium iodide-negative cells, it is unlikely that the immunoblot results are attributable to a small population of apoptotic cells. This is supported by the identical distribution of the fluorescence of cells transfected with R-LETD-M-EGFP and M-LETD-R-EGFP. If only a small portion of cells was responsible for the apparent caspase activity then one would expect that cells transfected with either R-LETD-M-EGFP or M-LETD-R-EGFP would have a bimodal distribution, which was not seen.
It is also unlikely that the transfection itself or induction with Ponasterone A activated caspase activity. Nearly identical results were obtained from the cells transfected by lipid reagents or calcium phosphate and when Ponasterone A induction was delayed for three days after transfection (data not shown). Ponasterone A was not responsible for the induction of caspase activity since both the 29.7-kDa and 29.1-kDa EGFP were detected from the expression of M-LETD-M-EGFP under the constitutive promoter pCMV for up to five days after transfection (data not shown). This indicates that the detected caspase activity was independent of exogenous agents and likely to be endogenous in origin.
We have avoided specifying which caspase is responsible for the endogenous caspase activity even though we have used the consensus sequence for caspase-8, LETD, in the construction of the plasmid. Many reports of overlapping specificities are in the literature (28, 30) , thus we cannot determine whether one caspase or many different caspases are responsible for this activity. However, it is apparent that this endogenous caspase activity is not just present in 293T cells since experiments performed with Cos-7 cells demonstrated similar results (data not shown).
The endogenous caspase activity in non-apoptotic cells can originate either from active caspases that are found during apoptosis or from their precursors, procaspases. The latter possibility is consistent with previous reports that some procaspases contain 1%-10% of the proteolytic activity found in active enzymes (14, 24) . Such small but detectable procaspase activity is the basis for the induced proximity model of caspase-8 activation (14) . The model suggests that clustering of procaspase-8 molecules accelerates the trans-cleavage and autoactivation of caspases by the inherent proteolytic activity of procaspases. Perhaps the same explanation also applies for the detection of active caspases from bacterial expressions of recombinant procaspases (27) .
Compartmentalization of procaspases, their cofactors, and substrates plays a major role in the regulation of apoptosis, and the precise localization of procaspases is controversial (6, 16, 19, 21, 38) .
However, compartmentalization cannot completely account for what prevents the low but detectable activity within cells from cleaving cellular substrates and activating other caspases in nonapoptotic cells. Cleavage of our construct proteins by caspase activity without inducing apoptosis further suggests the existence of regulatory mechanisms to tightly control the proteolytic activity.
Endogenous caspase inhibitors, such as inhibitors of apoptosis proteins (IAPs) have recently attracted considerable attention and may be central to this regulatory system (7, 34) . It is clear that IAPs inhibit active caspases, but the extent that IAPs inhibit endogenous caspase activity of procaspases is unknown (4, 36) . Perhaps the endogenous activity we detect is not inhibitable by IAPs; however, the downstream effect of this endogenous activity, the production of active caspases, is inhibited by IAPs, thus preventing apoptosis. Indeed, this endogenous activity of procaspases may be vital for the initiation of programmed cell death. For apoptosis to proceed, IAPs would need to be inhibited by smac/diablo (5), other inhibitors, and/or overwhelming activation of caspase 3 (7, 10, 34, 35) .
Since the marker is dependent on a number of different protease activities, including proteasomal degradation, it will be used in future studies to determine the rate of proteasomal degradation during apoptosis. In addition, we have established the feasibility of using the N-end rule as the basis of an assay for the enzymatic activity of an enzyme other than those involved in proteasomal degradation.
